NanoViricides Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	3.21	1.56	4.8	8.15	14.07	20.52
Cash & Short-Term Investments	3.21	1.56	4.8	8.15	14.07	20.52
Cash Growth	26.38%	-67.52%	-41.13%	-42.06%	-31.44%	49.66%
Other Current Assets	0.16	0.11	0.17	0.3	0.35	0.31
Total Current Assets	3.38	1.67	4.97	8.45	14.42	20.82
Net Property, Plant & Equipment	6.53	6.83	7.51	8.11	8.69	9.08
Other Intangible Assets	0.31	0.32	0.33	0.33	0.34	0.35
Other Long-Term Assets	0	0	0.01	0.01	0.08	0
Total Assets	10.22	8.82	12.82	16.9	23.49	30.26
Accounts Payable	1.04	1.28	1.1	0.39	0.27	0.23
Accrued Expenses	0.03	0.03	0.26	0.14	0.05	0.02
Short-Term Debt	-	-	-	-	0.09	0.1
Total Current Liabilities	1.07	1.31	1.36	0.53	0.41	0.35
Other Long-Term Liabilities	-	-	-	1.5	-	-
Total Long-Term Liabilities	-	-	-	1.5	-	-
Total Liabilities	1.07	1.31	1.36	2.03	0.41	0.35
Preferred Stock	0	0	0	0	0	0
Common Stock	0	0	0	0	0	0.01
Additional Paid-in Capital	163.99	156.36	150.84	145.95	145.57	144.29
Retained Earnings	-154.84	-148.84	-139.38	-131.08	-122.49	-114.39
Shareholders' Equity	9.15	7.52	11.46	14.87	23.08	29.91
Total Liabilities & Equity	10.22	8.82	12.82	16.9	23.49	30.26
Total Debt	-	0	0	0	0.09	0.1
Net Cash (Debt)	3.21	1.56	4.8	8.15	13.97	20.42
Net Cash Growth	106.17%	-67.52%	-41.13%	-41.67%	-31.58%	62.54%
Net Cash Per Share	0.17	0.10	0.40	0.70	1.21	1.87
Book Value	9.15	7.52	11.46	14.87	23.08	29.91
Book Value Per Share	0.49	0.50	0.97	1.28	2.00	2.74
Tangible Book Value	8.84	7.2	11.14	14.53	22.74	29.56
Tangible Book Value Per Share	0.47	0.48	0.94	1.25	1.97	2.71

SEC Filings: 10-K · 10-Q